Equine West Nile Virus combination vaccine. For the vaccination of healthy horses as an aid in the prevention of viremia caused by West Nile Virus, and as an aid in the prevention of equine encephalomyelitis due to Eastern and Western viruses, and tetanus.
Dosage: 1 ml IM, repeat in 3-4 weeks. Revaccinate annually.
Anaphylactoid reactions may occur. Antidote : Epinephrine.
U.S. Lic. No. 112.
Manufacturer: Zoetis
West Nile-Innovator + EWT Equine Vaccine
ZOETIS INC.
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Telephone: 269-359-4414 Customer Service: 888-963-8471 Website: www.zoetis.com Every effort has been made to ensure the accuracy of the information published. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the USA product label or package insert. West Nile-Innovator®+EWT
Zoetis
Encephalomyelitis-West Nile Virus Vaccine
Eastern & Western, Killed Virus
Tetanus Toxoid
INDICATIONS: For vaccination of healthy horses 10 months of age or older as an aid in the prevention of viremia caused by West Nile virus, and as an aid in the prevention of equine encephalomyelitis due to Eastern and Western viruses, and tetanus.
EFFICACY: Efficacy of the West Nile fraction was demonstrated in 10-month-old horses that received two doses of the vaccine and were challenged one year post-vaccination with West Nile virus. The vaccine protected 95% of the vaccinates against viremia, while 82% of the controls were viremic.
SAFETY: Field safety testing has demonstrated that this product is safe for use in horses 3 months of age or older. Efficacy has not been established in foals 3 months of age.
DOSE: Horses, inject one 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 4 weeks after the first dose. A 1 mL booster dose should be given annually. Early revaccination may be advisable when horses are faced with an outbreak or with other conditions which might make heavy exposure likely.
CAUTION: Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.
Thimerosal, neomycin and polymyxin B added as preservatives.
For Veterinary Use Only
Remove serial number and expiration date label and place on the animal’s medical chart.
U.S. Vet. License No. 190
Zoetis Inc., Kalamazoo, MI 49007, USA
1 mL
1 Dose
50024400
10 mL
10 Doses
50024100
CPN: 3690344.4